RT-LAMP Nucleic Acid Quantification via Isothermal Fluorescence

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current diagnostic methods for detecting and quantifying nucleic acids, such as those for SARS-COV-2 and colorectal cancer, face challenges in accuracy and speed, particularly in point-of-care settings where resources and equipment are limited.

Innovation Solution

The use of a unique, customizable set of primers in reverse transcription loop-mediated isothermal amplification (RT-LAMP) to improve the accuracy and speed of nucleic acid quantification, combined with a portable desktop RT-LAMP device for point-of-care diagnostics.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If RT-PCR is used for nucleic acid quantification, then measurement precision is improved, but time consumption increases and device complexity increases

Engineering Contradiction:
Improvenucleic acid quantification accuracyVSAvoidtime from sample collection to results
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent changes the fundamental parameter of temperature control from cyclic heating/cooling (RT-PCR) to constant temperature (RT-LAMP). This allows the reaction to proceed continuously at a single optimal temperature, eliminating the time-consuming thermal cycling steps while maintaining amplification efficiency and quantification accuracy through real-time fluorescence monitoring.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent replaces the mechanical thermal cycling system with a simple isothermal heating system. Instead of requiring a thermocycler that repeatedly heats and cools samples, the RT-LAMP system uses a single heating block maintained at constant temperature, significantly simplifying the equipment and reducing the time to obtain results.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Measurement precision

If RT-PCR is used for nucleic acid detection, then measurement precision is improved, but device complexity and cost increase

Engineering Contradiction:
Improvenucleic acid detection accuracyVSAvoidequipment requirements
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent replaces complex mechanical thermal cycling equipment with a simple isothermal heating device. The RT-LAMP system requires only a heating block maintained at constant temperature, eliminating the need for sophisticated thermocyclers, reducing both device complexity and operational cost while maintaining diagnostic accuracy.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent employs disposable reaction cartridges containing all necessary reagents for a single-use test. This eliminates the need for expensive, complex equipment and allows the system to be operated in resource-limited settings, providing accurate nucleic acid detection without requiring sophisticated infrastructure.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Speed

If RT-LAMP is used for rapid detection, then speed is improved, but measurement precision deteriorates

Engineering Contradiction:
Improvetime to resultVSAvoidquantification accuracy
Core Design Contradiction:
SpeedVSMeasurement precision

Solution Approach 1:

The patent incorporates real-time fluorescence monitoring with automated feedback control. The system continuously monitors fluorescence intensity during the isothermal amplification and uses this feedback to determine the cycle threshold (CT) value, enabling accurate quantification while maintaining rapid results. The feedback mechanism ensures that quantification is based on actual amplification kinetics rather than fixed cycling protocols.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The patent changes the detection parameter from end-point analysis to real-time kinetic monitoring. By measuring fluorescence intensity changes during the exponential growth phase of amplification and analyzing the slope and inflection points of the amplification curve, the system achieves both rapid results and accurate quantification, overcoming the traditional trade-off between speed and precision.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables rapid and accurate detection and quantification of nucleic acids, reducing the time from sample collection to results to approximately 25 minutes, and allows for reliable diagnostics in resource-limited settings.

Implementation Method 1

The detection of changes in fluorescence intensity during the reaction enables the user to follow the PCR reaction in real time

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Implementation Method 2

It uses an enzyme called reverse transcriptase to change a specific piece of RNA into a matching piece of DNA

Methodology Applied
Scientific EffectReverse transcription: Enzyme

Implementation Method 3

Reverse transcription-loop mediated isothermal amplification (RT-LAMP) uses an alternative method of DNA amplification based on DNA polymerase with strand displacement activity

Methodology Applied
Scientific EffectIsothermal amplification: Enzyme

Data Source

PatentUS20250179581A1Measurement of nucleic acids in a biological specimen using RT-lamp
Publication Date: 2025.06.05 RGT UNIV OF CALIFORNIA
  • US20250179581A1 patent drawing
  • US20250179581A1 patent drawing
  • US20250179581A1 patent drawing

AI summary

Methods and devices for utilizing reverse transcription loop-mediated isothermal amplification (RT-LAMP) to detect target DNA and RNA sequences for diagnostic and experimental assays, such as those for diagnosing and quantifying diseases, such as colorectal cancer and gastrointestinal disease, or pathogens, such as SARS-COV-2.